Sorafenib in Treating Non-Smokers or Former Light Smokers With Relapsed or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00754923 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: sorafenib

Sponsor

Ohio State University Comprehensive Cancer Center

Collaborators

[object Object]